Leptin has different roles in NAFLD, according to the disease stage; in initial stages it could act as a protection factor, but when NAFLD progresses, leptin acts as an inflammatory and fibrogenic agent. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.